Sectors

AAPG
Ascentage Pharma Group Internat
17.10
1 x 18.19
1 x 23.14
bid
ask
-
1.18
6.44%
1 @ 05:46 PM
17.41 +0.31 (1.81%)
Ytd-34.83%
1y-59.74%
17.10
day range
17.78
16.36
52 week range
42.47
Open17.78Prev Close18.28Low17.10High17.78Mkt Cap1.60B
Vol6.05KAvg Vol10.73KEPS-2.35P/EN/AForward P/E-16.50
Beta0.67Short Ratio2.76Inst. Own0.04%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning08-1950-d Avg18.21200-d Avg23.261yr Est47.44

AAPG News

12 Health Care Stocks Moving In Thursday's Pre-Market Session
benzinga.com
12 Health Care Stocks Moving In Thursday's Pre-Market Session

Gainers VolitionRX (AMEX:VNRX) shares increased by 102.2% to $0.69 during Thursday's pre-market

benzinga.com
BTIG Reiterates Buy on Ascentage Pharma Group, Maintains $48 Price Target

BTIG analyst Jeet Mukherjee reiterates Ascentage Pharma Group (NASDAQ:AAPG) with a Buy and maint

Transcript: Ascentage Pharma Group H1 2026 Earnings Conference Call
benzinga.com
Transcript: Ascentage Pharma Group H1 2026 Earnings Conference Call

On Thursday, Ascentage Pharma Group (NASDAQ:AAPG) discussed quarterly financial results during its e

Ascentage Pharma Group International (AAPG) Q2 2026 Earnings Call Transcript
seekingalpha.com
Ascentage Pharma Group International (AAPG) Q2 2026 Earnings Call Transcript

Ascentage Pharma Group International (AAPG) Q2 2026 Earnings Call Transcript

Ascentage Pharma Group International H1 Earnings Call Highlights
marketbeat.com
Ascentage Pharma Group International H1 Earnings Call Highlights

Ascentage Pharma Group International NASDAQ: AAPG reported first-half 2026 revenue growth as it cont

benzinga.com
Reported Earlier, Ascentage Pharma Group H1 EPS $(0.32) Beats $(0.44) Estimate, Sales $44.541M Beat

Ascentage Pharma Group (NASDAQ:AAPG) reported quarterly losses of $(0.32) per share which beat the a

Ascentage Pharma Reports 2026 Interim Unaudited Financial Results and Provides Business Updates
globenewswire.com
Ascentage Pharma Reports 2026 Interim Unaudited Financial Results and Provides Business Updates

Revenue for the first half of 2026 increased 29% year-over-year to US$44.5 million (RMB302.2 million

Ascentage Pharma to Participate in the Evercore 2nd Annual China Biotech Summit
globenewswire.com
Ascentage Pharma to Participate in the Evercore 2nd Annual China Biotech Summit

ROCKVILLE, Md., Aug. 13, 2026 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ: AAPG

Ascentage Pharma Group International (NASDAQ:AAPG) Shares Gap Up   – Still a Buy?
defenseworld.net
Ascentage Pharma Group International (NASDAQ:AAPG) Shares Gap Up – Still a Buy?

Shares of Ascentage Pharma Group International - Unsponsored ADR (NASDAQ: AAPG - Get Free Report) ga

CORRECTION: Ascentage Pharma to Report 2026 Six Month Interim Results and Provide Corporate Update on August 19, 2026
globenewswire.com
CORRECTION: Ascentage Pharma to Report 2026 Six Month Interim Results and Provide Corporate Update o

In a release issued under the same headline earlier today by Ascentage Pharma Group International (N

Ascentage Pharma to Report 2026 Six Month Interim Results and Provide Corporate Update on August 19, 2026
globenewswire.com
Ascentage Pharma to Report 2026 Six Month Interim Results and Provide Corporate Update on August 19,

ROCKVILLE, Md., Aug. 05, 2026 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ: AAPG

Ascentage Pharma Appoints Dr. Faiçal Miyara as Chief Business Officer and Jim Ziegler as Chief Commercial Officer
globenewswire.com
Ascentage Pharma Appoints Dr. Faiçal Miyara as Chief Business Officer and Jim Ziegler as Chief Comme

ROCKVILLE, Md., Aug. 02, 2026 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ: AAPG

Wall Street Analysts Predict a 160.09% Upside in Ascentage Pharma Group International - Unsponsored ADR (AAPG): Here's What You Should Know
zacks.com
Wall Street Analysts Predict a 160.09% Upside in Ascentage Pharma Group International - Unsponsored

The average of price targets set by Wall Street analysts indicates a potential upside of 160.1% in A

Ascentage Pharma Chairman and CEO Dr. Dajun Yang Named to The Medicine Maker Power List 2026
globenewswire.com
Ascentage Pharma Chairman and CEO Dr. Dajun Yang Named to The Medicine Maker Power List 2026

ROCKVILLE, Md. and SUZHOU, China, July 26, 2026 (GLOBE NEWSWIRE) -- Ascentage Pharma Group Internati

How Much Upside is Left in Ascentage Pharma Group International - Unsponsored ADR (AAPG)? Wall Street Analysts Think 152.23%
zacks.com
How Much Upside is Left in Ascentage Pharma Group International - Unsponsored ADR (AAPG)? Wall Stree

The consensus price target hints at a 152.2% upside potential for Ascentage Pharma Group Internation

ON Semiconductor, SanDisk And Other Big Stocks Moving Lower In Friday’s Pre-Market Session
benzinga.com
ON Semiconductor, SanDisk And Other Big Stocks Moving Lower In Friday’s Pre-Market Session

U.S. stock futures down, Nasdaq 100 futures drop over 1%. ON Semi to acquire Synaptics, ON shares fa

Ascentage Pharma Presents Multiple Clinical Updates at EHA2026 Congress
globenewswire.com
Ascentage Pharma Presents Multiple Clinical Updates at EHA2026 Congress

ROCKVILLE, Md. and SUZHOU, China, June 14, 2026 (GLOBE NEWSWIRE) -- Ascentage Pharma Group Internati

Ascentage Pharma Presents Data on Olverembatinib in CML-LBP and Ph+ BCP-ALL at ASCO 2026
globenewswire.com
Ascentage Pharma Presents Data on Olverembatinib in CML-LBP and Ph+ BCP-ALL at ASCO 2026

ROCKVILLE, Md. and SUZHOU, China, May 31, 2026 (GLOBE NEWSWIRE) -- Ascentage Pharma Group Internatio

Ascentage Pharma Presents Updated Clinical Data for Olverembatinib as Second-Line Therapy in CML-CP at ASCO 2026
globenewswire.com
Ascentage Pharma Presents Updated Clinical Data for Olverembatinib as Second-Line Therapy in CML-CP

ROCKVILLE, Md. and SUZHOU, China, May 31, 2026 (GLOBE NEWSWIRE) -- Ascentage Pharma Group Internatio

Ascentage Pharma Presents Its First Dataset on MDM2-p53 Inhibitor Alrizomadlin (APG-115) in Pediatric Solid Tumors at ASCO 2026
globenewswire.com
Ascentage Pharma Presents Its First Dataset on MDM2-p53 Inhibitor Alrizomadlin (APG-115) in Pediatri

ROCKVILLE, Md. and SUZHOU, China, May 31, 2026 (GLOBE NEWSWIRE) -- Ascentage Pharma Group Internatio

Ascentage Pharma Releases Latest Clinical Data from Multiple Trials at ASCO 2026
globenewswire.com
Ascentage Pharma Releases Latest Clinical Data from Multiple Trials at ASCO 2026

ROCKVILLE, Md. and SUZHOU, China, May 21, 2026 (GLOBE NEWSWIRE) -- Ascentage Pharma Group Internatio

Ascentage Pharma to Present 17 Clinical Advances at 2026 European Hematology Association Congress
globenewswire.com
Ascentage Pharma to Present 17 Clinical Advances at 2026 European Hematology Association Congress

ROCKVILLE, Md. and SUZHOU, China, May 12, 2026 (GLOBE NEWSWIRE) -- Ascentage Pharma Group Internatio

Applied Digital, Simply Good Foods And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
benzinga.com
Applied Digital, Simply Good Foods And Other Big Stocks Moving Lower In Thursday's Pre-Market Sessio

U.S. stock futures lower on Thursday with Applied Digital Corp. (APLD) falling sharply in pre-market

12 Health Care Stocks Moving In Wednesday's Pre-Market Session
benzinga.com
12 Health Care Stocks Moving In Wednesday's Pre-Market Session

Why nCino Shares Are Trading Higher By 18%; Here Are 20 Stocks Moving Premarket
benzinga.com
Why nCino Shares Are Trading Higher By 18%; Here Are 20 Stocks Moving Premarket

Shares of nCino Inc (NASDAQ: NCNO) jumped 18% in pre-market trading after reporting strong Q4 result

Earnings Scheduled For March 25, 2026
benzinga.com
Earnings Scheduled For March 25, 2026

Monte Rosa Therapeutics, Ventyx Biosciences, United Microelectronics And Other Big Stocks Moving Higher On Wednesday
benzinga.com
Monte Rosa Therapeutics, Ventyx Biosciences, United Microelectronics And Other Big Stocks Moving Hig

Novo Nordisk, Sable Offshore, StoneCo And Other Big Stocks Moving Higher On Tuesday
benzinga.com
Novo Nordisk, Sable Offshore, StoneCo And Other Big Stocks Moving Higher On Tuesday

Cementos Pacasmayo, Rezolve AI, Emerald Holding And Other Big Stocks Moving Higher On Monday
benzinga.com
Cementos Pacasmayo, Rezolve AI, Emerald Holding And Other Big Stocks Moving Higher On Monday

This Hasbro Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
benzinga.com
This Hasbro Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday

This Docebo Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Wednesday
benzinga.com
This Docebo Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Wednesday

Keurig Dr Pepper, Valneva, Venu Holding And Other Big Stocks Moving Lower On Monday
benzinga.com
Keurig Dr Pepper, Valneva, Venu Holding And Other Big Stocks Moving Lower On Monday

benzinga.com
Earnings Scheduled For August 20, 2025

US Stocks Likely To Open Mixed As Trump Issues Tariff Letters: Experts Peg AI Investments As 'Durable Drivers Of Returns'
benzinga.com
US Stocks Likely To Open Mixed As Trump Issues Tariff Letters: Experts Peg AI Investments As 'Durabl

U.S. stock futures were fluctuating on Tuesday after trimming gains on Monday. Futures of major benc

Penguin Solutions, Merit Medical Systems And 3 Stocks To Watch Heading Into Tuesday
benzinga.com
Penguin Solutions, Merit Medical Systems And 3 Stocks To Watch Heading Into Tuesday

PDD Holdings Posts Weak Results, Joins EHang Holdings And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
benzinga.com
PDD Holdings Posts Weak Results, Joins EHang Holdings And Other Big Stocks Moving Lower In Tuesday's

Bitdeer Tech And Tempus AI Are Among Top 18 Mid-Cap Gainers Last Week (Apr 21-Apr 25): Are The Others In Your Portfolio?
benzinga.com
Bitdeer Tech And Tempus AI Are Among Top 18 Mid-Cap Gainers Last Week (Apr 21-Apr 25): Are The Other

Top mid-cap stock performers last week: Ascentage Pharma, Ardagh Metal, Bitdeer Tech, Pegasystems, I

benzinga.com
Earnings Scheduled For March 27, 2025